Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Hepatology home hospital program for people with advanced liver disease

Official title: HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease

Run by Massachusetts General Hospital · NCT05205954 · Data updated 2026-11-12

This will try a hospital-at-home program that brings hepatology care to adults with cirrhosis who would otherwise need inpatient care.

More Cirrhosis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations2 sites (Boston, Massachusetts and 1 other locations)
StatusRecruiting
StartedJuly 21, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 7, 2026
Trial IDNCT05205954 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with cirrhosis who present to the ED or inpatient medicine service and have ascites requiring diuretics or paracentesis, hepatic hydrothorax requiring diuretics, or hepatic encephalopathy requiring medications, with MELD ≤20 and who meet MGH Home Hospital criteria are ideal candidates.

Probably not a fit

Patients with prior solid-organ transplant, on hemodialysis, MELD >20, very low cognitive screening (S-ANT1 <10), current hemodynamically significant GI bleeding or alcohol withdrawal, those needing routine controlled substances, or judged unsuitable by clinicians are unlikely to benefit from this home-based program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot interventional program offers inpatient-level hepatology care delivered at home by the Massachusetts General Hospital Home Hospital team. Eligible adults with cirrhosis presenting to the emergency department or general medicine service who have ascites, hepatic hydrothorax, or hepatic encephalopathy may be enrolled. Patients with prior solid-organ transplant, on hemodialysis, MELD >20, low cognitive screening (S-ANT1 <10), active hemodynamically significant GI bleed or alcohol withdrawal, or needing routine controlled substances are excluded. The program aims to replace or shorten hospital stays by providing monitoring, treatments, and procedures in the home setting under hospital oversight.

Why it matters

Potential benefit: If successful, the program could let eligible patients receive hospital-level hepatology care at home, reducing hospital stays and improving comfort and convenience.

How similar studies have gone: Hospital-at-home models have shown positive results for general medical admissions and some chronic conditions, but there is limited published data specifically on home hospital care for advanced liver disease.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adult patients ≥ 18 years old with diagnosis of cirrhosis based on histology, radiology, and/or elastography presenting to the emergency department or inpatient general medicine service
2. Patients must have one of the following:

   1. Ascites (requiring diuretics or serial large volume paracenteses)
   2. Hepatic hydrothorax (requiring diuretics)
   3. Hepatic encephalopathy (requiring medications)

Exclusion Criteria: All existing MGB home hospital criteria apply, with the following taking precedent for this specific condition

1. History of solid organ transplantation
2. On hemodialysis
3. MELD score \> 20
4. Score \<10 on Simplified Animal Naming Test (S-ANT1)
5. Current admission for hemodynamically significant GI bleeding or alcohol withdrawal
6. Require routine administration of controlled substances
7. Those deemed ineligible based on the MGH Home Hospital, inpatient medicine or hepatology clinician evaluation

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.